Hospira, Inc. (NYSE:HSP)

CAPS Rating: 2 out of 5

A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care.

Recs

0
Player Avatar latinoeconomist (30.11) Submitted: 8/1/2011 3:27:29 AM : Outperform Start Price: $51.43 HSP Score: -38.00

High growth potential.

Report this Post Reply

Featured Broker Partners


Advertisement